Overactive Bladder Drugs May Not Raise Dementia Risk

Overactive bladder drugs may not raise dementia risk, according to a new study published in JAMA Network Open.

Dietary paradox in Southern Europe where healthy diets coexist with rising diabetes rates, puzzling researchers.

Stanford Medicine research identifies brain scan firing patterns that predict Alzheimer's risk years before memory loss begins, offering…

A 16-week trial shows daily 60g peanut intake may alter brain insulin sensitivity in older adults, particularly in…

Scientists identify blood markers linked to brain aging during menopause, offering a new window into dementia risk and…

Blood test detects joint damage in ankylosing spondylitis with strong accuracy, measuring specific proteins.

The FDA has approved tildrakizumab for psoriatic arthritis treatment, expanding its use beyond plaque psoriasis.

Clinicians increasingly rely on non-federal health guidance as trust in federal agencies declines, seeking evidence-based resources.

AI in healthcare risks widening disparities without stronger ethics, as experts warn marginalized groups face greater dangers than…

On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B…